Israeli media described the two-hour address delivered May 25 by Hezbollah Secretary-General Hassan Nasrallah as the “coughing speech.” Right after the televised speech, Israel’s Military Intelligence issued an assessment that Nasrallah, who had not been seen in public for weeks, appears to have contracted the coronavirus but refuses to take a test. Nasrallah, who appeared thin and pale, obviously had trouble breathing as he coughed his way through the speech, and his medical condition overshadowed its more interesting contents.
In fact, two speeches delivered at almost the same time — one in Beirut and one in the Gaza Strip, one by the head of a Sunni terrorist organization (Hamas Gaza leader Yahya Sinwar) and the other by a Shiite one (Hezbollah’s Nasrallah) — conveyed the same message to Israel. Both warned that Israel risks war if it tries to change the status quo in Jerusalem, if it takes any unilateral steps at Al-Aqsa Mosque compound, one of Islam’s holiest sites. Nasrallah even described this future conflagration as a “regional war.”
“Everyone is focusing on his cough,” a former senior Israeli intelligence source told Al-Monitor this week on condition of anonymity. “They are missing the point. Even if he has the coronavirus, he will most likely recover. Maybe spending 15 years in airless bunkers has also affected his breathing. Either way, in my estimation he will live to cough for many years.” According to the source, the main takeaway from the speech is Nasrallah’s message and the fact that it appeared almost coordinated with Sinwar’s appearances in Gaza this week.
“Nasrallah should be taken seriously; he is Israel’s most credible enemy, he usually doesn’t make empty threats,” a senior Israeli security source told Al-Monitor on condition of anonymity. “The fact that he joined Sinwar at this timing and announced that any unilateral Israel move in Jerusalem would lead to war should be treated in Jerusalem as a very serious warning.”
AL-MONITOR All-Access gives you unlimited access to all our journalism, the full Daily Briefing, exclusive interviews, premium newsletters, and live events — for less than $2/week.